By:  Christina England 07 September 2010 GlaxoSmithKline the drug giants, have spent the last few days trying to stay off the bottom of the FTSE 100, especially after the UK’s Medicines and Healthcare Products Regulatory Agency said that it’s diabetes treatment Avandia should be pulled from sale, over concerns that it can lead to heart […]